LINCOLN

Lincoln Pharmaceuticals Share Price Lincoln Pharmaceuticals

₹593.3
-6.45 (-1.08%)
25 April, 2024 07:59 BSE: 531633 NSE: LINCOLNISIN: INE405C01035

Start SIP in Lincoln Pharmaceuticals

Start SIP

Lincoln Pharmaceuticals Performance

Day Range

  • Low 590
  • High 605
₹ 593

52 Week Range

  • Low 365
  • High 755
₹ 593
  • Open Price605
  • Previous Close600
  • Volume29475

Lincoln Pharmaceuticals Share Price

  • Over 1 Month -1.41%
  • Over 3 Month -10.79%
  • Over 6 Month +23%
  • Over 1 Year +49.33%

Lincoln Pharmaceuticals Key Statistics

P/E Ratio 13.6
PEG Ratio 0.6
Market Cap Cr 1,188
Price to Book Ratio 2.4
EPS 36.2
Dividend 0.3
Relative Strength Index 45.27
Money Flow Index 48.31
MACD Signal -10.42
Average True Range 20.16
Lincoln Pharmaceuticals Financials
IndicatorDec 2023Sep 2023Jun 2023Mar 2023
Oper Rev Qtr Cr 146156136112
Operating Expenses Qtr Cr 11712511596
Operating Profit Qtr Cr 30312117
Depreciation Qtr Cr 3332
Interest Qtr Cr 0001
Tax Qtr Cr 10964
Net Profit Qtr Cr 28281913
IndicatorMar 2023
Total Revenue Annual Cr 533
Operating Expenses Annual Cr 421
Operating Profit Annual in Cr 89
Depreciation Cr 9
Interest Annual Cr 2
Tax Annual Cr 28
Net Profit Annual Cr 73
IndicatorMar 2023
Cash from Operating Activity Annual Cr 39
Cash from Investing Activity Annual Cr -37
Cash from Financing Annual Activity Cr -5
Net Cash Flow Annual Cr -2
IndicatorMar 2023
Total ShareHolders Funds Annual Cr 502
Fixed Assets Annual Cr 157
Total Non Current Assets Annual Cr 220
Total Current Assets Annual Cr 367
Total Assets Annual Cr 587
IndicatorMar 2023
Book Value Per Share Annual Rs 251
ROE Annual % 15
ROCE Annual % 20
Total Debt to Total Equity Annual -
EBDIT Annual Margin % 22
IndicatorDec 2023Sep 2023Jun 2023Mar 2023
Oper Rev Qtr Cr 146156136112
Operating Expenses Qtr Cr 11712511596
Operating Profit Qtr Cr 30312117
Depreciation Qtr Cr 3332
Interest Qtr Cr 0001
Tax Qtr Cr 10964
Net Profit Qtr Cr 28281913
IndicatorMar 2023
Total Revenue Annual Cr 533
Operating Expenses Annual Cr 421
Operating Profit Annual in Cr 89
Depreciation Cr 9
Interest Annual Cr 2
Tax Annual Cr 28
Net Profit Annual Cr 73
IndicatorMar 2023
Cash from Operating Activity Annual Cr 39
Cash from Investing Activity Annual Cr -37
Cash from Financing Annual Activity Cr -5
Net Cash Flow Annual Cr -2
IndicatorMar 2023
Total ShareHolders Funds Annual Cr 502
Fixed Assets Annual Cr 157
Total Non Current Assets Annual Cr 220
Total Current Assets Annual Cr 367
Total Assets Annual Cr 587
IndicatorMar 2023
Book Value Per Share Annual Rs 251
ROE Annual % 15
ROCE Annual % 20
Total Debt to Total Equity Annual -
EBDIT Annual Margin % 22

Lincoln Pharmaceuticals Technicals

EMA & SMA

Current Price
₹593.3
-6.45 (-1.08%)
pointer
  • Bullish Moving Average
  • ___
  • 6
  • Bearish Moving Average
  • ___
  • 10
  • 20 Day
  • ₹598.94
  • 50 Day
  • ₹615.36
  • 100 Day
  • ₹611.72
  • 200 Day
  • ₹568.43
  • 20 Day
  • ₹598.23
  • 50 Day
  • ₹627.88
  • 100 Day
  • ₹639.64
  • 200 Day
  • ₹568.19

Lincoln Pharmaceuticals Resistance and Support

PIVOT
₹596.15
Resistance
First Resistance 602.20
Second Resistance 611.10
Third Resistance 617.15
RSI 45.27
MFI 48.31
MACD Single Line -10.42
MACD -9.05
Support
First Resistance 587.25
Second Resistance 581.20
Third Resistance 572.30

Lincoln Pharmaceuticals Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 31,273 1,812,896 57.97
Week 34,520 1,953,464 56.59
1 Month 50,080 2,491,472 49.75
6 Month 146,829 5,390,104 36.71

Lincoln Pharmaceuticals Result Highlights

Lincoln Pharmaceuticals Synopsis

NSE-Medical-Diversified

Lincoln Pharmace is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 510.31 Cr. and Equity Capital is Rs. 20.03 Cr. for the Year ended 31/03/2023. Lincoln Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 20/01/1995 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24230GJ1995PLC024288 and registration number is 024288.
Market Cap 1,188
Sales 551
Shares in Float 1.00
No of funds 34
Yield 0.25
Book Value 2.37
U/D Vol ratio 0.8
LTDebt / Equity
Alpha 0.09
Beta 0.86

Lincoln Pharmaceuticals

Owner NameMar-24Dec-23Sep-23Jun-23
Promoters 49.53%49.8%50.53%48.67%
Mutual Funds
Foreign Portfolio Investors 3.93%3.22%2.59%1.74%
Individual Investors 37.36%37.78%37.47%37.32%
Others 9.18%9.2%9.41%12.27%

Lincoln Pharmaceuticals Management

Name Designation
Mr. Kishor M Shah Chairman
Mr. Mahendra G Patel Managing Director
Mr. Hashmukh I Patel Whole Time Director
Mr. Munjal M Patel Whole Time Director
Mr. Ashish R Patel Whole Time Director
Mr. Rajnikant G Patel Non Executive Director
Mr. Meha M Patel Independent Director
Mr. Saurin J Parikh Independent Director
Mr. Pirabhai R Suthar Independent Director

Lincoln Pharmaceuticals Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Lincoln Pharmaceuticals Corporate Action

Date Purpose Remarks
2024-02-08 Quarterly Results
2023-11-02 Quarterly Results
2023-08-10 Quarterly Results
2023-05-25 Audited Results & Dividend
2023-02-09 Quarterly Results

Lincoln Pharmaceuticals MF Shareholding

Name Amount(cr)

Lincoln Pharmaceuticals FAQs

What is Share Price of Lincoln Pharmaceuticals ?

Lincoln Pharmaceuticals share price is ₹593 As on 25 April, 2024 | 07:45

What is the Market Cap of Lincoln Pharmaceuticals ?

The Market Cap of Lincoln Pharmaceuticals is ₹1188.4 Cr As on 25 April, 2024 | 07:45

What is the P/E ratio of Lincoln Pharmaceuticals ?

The P/E ratio of Lincoln Pharmaceuticals is 13.6 As on 25 April, 2024 | 07:45

What is the PB ratio of Lincoln Pharmaceuticals ?

The PB ratio of Lincoln Pharmaceuticals is 2.4 As on 25 April, 2024 | 07:45

Q2FY23